Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Glucagon-like peptide-1 receptor co-agonists for the treatment of metabolic disease
We had to reschedule a couple of appointments and we really appreciated that they were able to reschedule us with no issues
Category 2 means the FDA has determined that the substance "may present significant safety risks" when used in compounding
You'll likely see your healthcare provider for regular check-ups to make sure the drug is working, monitor for possible side effects, and make dosing adjustments as needed
Wegovy is currently only approved for obesity, while Ozempic and Mounjaro are FDA-approved for type 2 diabetes treatment
Formulation: BP-C1-57 (10mg), TB-500 (10mg), GHK-Cu (50mg), KPV (10mg)
US$ 29.01
US$ 27.62
US$ 25.75
US$ 27.70
